Lovell Drugs signs supply deal for medicinal cannabis
TORONTO — Canada’s Lovell Drugs has entered into a definitive agreement with Maricann Group Inc. to be the exclusive supplier of medicinal cannabis to its pharmacies. Maricann said that Lovell has begun dispensing medical marijuana to its patients, registering and filling its first medicinal cannabis prescription registered and fulfilled on Dec. 1. The drug chain
